Design, synthesis and inhibitory activity of novel 2, 3-dihydroquinolin-4(1H)-one derivatives as potential succinate dehydrogenase inhibitors

Wei Cheng,Yingkun Yan,Tingting Xiao,Guilan Zhang,Tingting Zhang,Tong Lu,Wenjing Jiang,Jingwen Wang,Xiaorong Tang
DOI: https://doi.org/10.1016/j.ejmech.2021.113246
IF: 7.088
2021-03-01
European Journal of Medicinal Chemistry
Abstract:<p>Thirty-three new 2, 3-dihydroquinolin-4(1<em>H</em>)-one analogues were designed, synthesized and characterized by IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR and HRMS. The crystal structures of compounds <strong>2g</strong> and <strong>4l</strong> were characterized by single crystal X-ray diffraction. Their antifungal activities were determined against five plant pathogenic fungi namely <em>Rhizoctonia solani</em>, <em>Fusarum graminearum</em>, <em>Helminthosporium maydis</em>, <em>Sclerotinia sclerotiorum</em> and <em>Botrytis cinerea</em>. The results indicated that most of them revealed significant antifungal activity at 20 mg/L. Compound <strong>4e</strong> showed the strongest antifungal activity against <em>Botrytis cinerea</em> and had better effects than the commercial fungicide fluopyram. Meanwhile, the active compounds were evaluated for their inhibitory activities against succinate dehydrogenase (SDH). The results displayed that they exhibited excellent activity. Compound <strong>4e</strong> had better inhibitory activity than fluopyram. The molecular modeling results demonstrated that compound <strong>4e</strong> could strongly bind to and interact with the binding sites of SDH. The inhibitory activity of 2, 3-dihydroquinolin-4(1<em>H</em>)-one derivatives against SDH has been reported for the first time.</p>
chemistry, medicinal
What problem does this paper attempt to address?